SMO ClinPlus Co. Ltd. Capital Reinvestment Ratio

Latest as of December 2025: 0.22x

SMO ClinPlus Co. Ltd. capital reinvestment ratio. SMO ClinPlus Co. Ltd. (301257) has a Capital Reinvestment Ratio of 0.22x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥35.69 Million) in capital expenditures (CN¥7.83 Million). Check SMO ClinPlus Co. Ltd. (301257) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.22x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥35.69 Million
CNY

Capital Expenditures

CN¥7.83 Million
CNY

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of SMO ClinPlus Co. Ltd. (2019–2025)

Capital reinvestment ratio of SMO ClinPlus Co. Ltd. from 2019 to 2025. This chart tracks SMO ClinPlus Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods. Also explore SMO ClinPlus Co. Ltd. net asset momentum to track the company's year-over-year net asset growth rate.

SMO ClinPlus Co. Ltd. Capital Reinvestment Ratio by Year (2019–2025)

SMO ClinPlus Co. Ltd. capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see cash flow conversion of SMO ClinPlus Co. Ltd..

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.22x CN¥35.69 Million CN¥7.83 Million ▲ +146.0%
2023 0.09x CN¥114.85 Million CN¥10.25 Million ▼ -54.6%
2022 0.20x CN¥40.44 Million CN¥7.95 Million ▲ +85.4%
2021 0.11x CN¥41.52 Million CN¥4.40 Million ▼ -41.7%
2020 0.18x CN¥22.45 Million CN¥4.08 Million ▲ +68.6%
2019 0.11x CN¥45.53 Million CN¥4.91 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow